Peripheral blood T-cell clonality in mycosis fungoides and nonlymphoma controls

Diagnostic Molecular Pathology

Volumn 12, Issue 3, 2003, Pages 142-150

  Muche, J Marcus ^a,b   Sterry, Wolfram ^a   Gellrich, Sylke ^a   Rzany, Berthold ^a   Audring, Heike ^a   Lukowsky, Ansgar ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Westfries Gasthuis Hoorn ^*  (Netherlands)

Author keywords

Autoimmunity; Cutaneous T cell lymphoma; Healthy donors; Mycosis fungoides; Prognosis; Skin cancer; T cell clonality

Indexed keywords

ADULT; AGED; ARTICLE; AUTOIMMUNITY; CANCER STAGING; CLONAL VARIATION; CONTROLLED STUDY; FEMALE; FLUORESCENCE; HUMAN; HUMAN TISSUE; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; MYCOSIS FUNGOIDES; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; SKIN BIOPSY; T CELL LYMPHOMA; T LYMPHOCYTE; TUMOR CELL;

EID: 0041887034     PISSN: 10529551     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019606-200309000-00005     Document Type: Article

References (35)

1. Willemze R, Kerl H, Sterry W, et al. EORTC classification for primary cutaneous lymphomas: A proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. Blood. 1997;90:354-371.
2. Bottaro M, Berti E, Biondi A, et al. Heteroduplex analysis of T-cell receptor gamma gene rearrangements for diagnosis and monitoring of cutaneous T-cell lymphomas. Blood. 1994;83:3271-3278.
3. Trainor KJ, Brisco MJ, Wan JH, et al. Gene rearrangement in B- and T-lymphoproliferative disease detected by the polymerase chain reaction. Blood. 1991;78:192-196.
4. Wood GS, Tung RM, Haeffner AC, et al. Detection of clonal T-cell receptor gamma gene rearrangements in early mycosis fungoides/Sezary syndrome by polymerase chain reaction and denaturing gradient gel electrophoresis (PCR/DGGE). J Invest Dermatol. 1994;103:34-41.
5. Delfau-Larue MH, Dalac S, Lepage E, et al. Prognostic significance of a polymerase chain reaction-detectable dominant T-lymphocyte clone in cutaneous lesions of patients with mycosis fungoides. Blood. 1998;92:3376-3380.
6. Fraser-Andrews EA, Woolford AJ, Russell Jones R, et al. Detection of a peripheral blood T cell clone is an independent prognostic marker in mycosis fungoides. J Invest Dermatol 2000;114:117-121.
7. Muche JM, Lukowsky A, Asadullah K, et al. Demonstration of frequent occurrence of clonal T cells in the peripheral blood of patients with primary cutaneous T-cell lymphoma. Blood. 1997;90:1636-1642.
8. Theodorou I, Delfau-Larue MH, Bigorgne C, et al. Cutaneous T-cell infiltrates: analysis of T-cell receptor gamma gene rearrangement by polymerase chain reaction and denaturing gradient gel electrophoresis. Blood. 1995;86:305-310.
9. Chamberlain WD, Falta MT, Kotzin BL. Functional subsets within clonally expanded CD8(+) memory T cells in elderly humans. Clin Immunol. 2000;94:160-172.
10. Lantelme E, Granziero L, Angman L, et al. Clonal predominance, but preservation of a polyclonal reservoir, in the normal alpha beta T-cell repertoire. Hum Immunol. 1997;53:49-56.
11. Posnett DN, Sinha R, Kabak S, et al. Clonal populations of T cells in normal elderly humans: The T cell equivalent to "benign monoclonal gammapathy." J Exp Med. 1994;179:609-618.
12. Schwab R, Szabo P, Manavalan JS, et al. Expanded CD4+ and CD8+ T cell clones in elderly humans. J Immunol. 1997;158:4493-4499.
13. Shen DF, Doukhan L, Kalams S, et al. High-resolution analysis of T-cell receptor beta-chain repertoires using DNA heteroduplex tracking: generally stable, clonal CD8+ expansions in all healthy young adults. J Immunol Methods. 1998;215:113-121.
14. Wack A, Cossarizza A, Heltai S, et al. Age-related modifications of the human alphabeta T cell repertoire due to different clonal expansions in the CD4+ and CD8+ subsets. Int Immunol. 1998;10:1281-1288.
15. Esin S, Gul A, Hodara V, et al. Peripheral blood T cell expansions in patients with Behcet's disease. Clin Exp Immunol. 1997;107:520-527.
16. Hall FC, Thomson K, Procter J, et al. TCR beta spectratyping in RA: evidence of clonal expansions in peripheral blood lymphocytes. Ann Rheum Dis. 1998;57:319-322.
17. Kolowos W, Herrmann M, Ponner BB, et al. Detection of restricted junctional diversity of peripheral T cells in SLE patients by spectratyping. Lupus. 1997;6:701-707.
18. Delfau-Larue MH, Laroche L, Wechsler J, et al. Diagnostic value of dominant T-cell clones in peripheral blood in 363 patients presenting consecutively with a clinical suspicion of cutaneous lymphoma. Blood. 2000;96:2987-2992.
19. Beylot-Barry M, Sibaud V, Thiebaut R, et al. Evidence that an identical T cell clone in skin and peripheral blood lymphocytes is an independent prognostic factor in primary cutaneous T cell lymphomas. J Invest Dermatol. 2001;117:920-926.
20. Dippel E, Klemke D, Hummel M, et al. T-cell clonality of undetermined significance. Blood. 2001;98:247-248.
21. Bakels V, van Oostveen JW, Gordijn RL, et al. Frequency and prognostic significance of clonal T-cell receptor beta- gene rearrangements in the peripheral blood of patients with mycosis fungoides. Arch Dermatol. 1992;128:1602-1607.
22. Muche JM, Lukowsky A, Ahnhudt C, et al. Peripheral blood T cell clonality in mycosis fungoides - An independent prognostic marker? J Invest Dermatol. 2000;115:504-505.
23. Laetsch B, Haffner AC, Dobbeling U, et al. CD4 + /CD7- T cell frequency and polymerase chain reaction-based clonality assay correlate with stage in cutaneous T cell lymphomas. J Invest Dermatol. 2000;114:107-111.
24. Kim YH, Jensen RA, Watanabe GL, et al. Clinical stage IA (limited patch and plaque) mycosis fungoides. A long-term outcome analysis. Arch Dermatol. 1996;132:1309-1313.
25. Bunn PA Jr, Lamberg SI. Report of the Committee on Staging and Classification-Cutaneous T-Cell Lymphomas. Cancer Treat Rep. 1979;63:725-728.
26. Balch CM, Buzaid AC, Atkins MB, et al. A new American Joint Committee on Cancer staging system for cutaneous melanoma. Cancer. 2000;88:1484-1491.
27. Lukowsky A, Richter S, Dijkstal K, et al. A T-cell receptor gamma polymerase chain reaction assay using capillary electrophoresis for the diagnosis of cutaneous T-cell lymphomas. Diagn Mol Pathol. 2002;11:59-66.
28. Klemke CD, Dippel E, Dembinski A, et al. Clonal T cell receptor gamma-chain gene rearrangement by PCR-based GeneScan analysis in the skin and blood of patients with parapsoriasis and early-stage mycosis fungoides. J Pathol. 2002;197:348-354.
29. Halapi E, Jeddi-Tehrani M, Blucher A, et al. Diverse T-cell receptor CDR3 length patterns in human CD4+ and CD8+ T lymphocytes from newborns and adults. Scand J Immunol. 1999;49:149-154.
30. Kato T, Kurokawa M, Sasakawa H, et al. Analysis of accumulated T cell clonotypes in patients with systemic lupus erythematosus. Arthritis Rheum. 2000;43:2712-2721.
31. Kolowos W, Gaipl US, Voll RE, et al. CD4 positive peripheral T cells from patients with systemic lupus erythematosus (SLE) are clonally expanded. Lupus. 2001;10:321-331.
32. Mazzocchi A, Belli F, Mascheroni L, et al. Frequency of cytotoxic T lymphocyte precursors (CTLp) interacting with autologous tumor via the T-cell receptor: limiting dilution analysis of specific CTLp in peripheral blood and tumor-invaded lymph nodes of melanoma patients. Int J Cancer 1994;58:330-339.
33. Breit TM, Wolvers-Tettero IL, van Dongen JJ. Receptor diversity of human T-cell receptor gamma delta expressing cells. Prog Histochem Cytochem. 1992;26:182-193.
34. Kaltoft K, Bisballe S, Sterry N. Sézary syndrome is characterized by genotraumatic cells. In: Lambert WC, ed. Basic mechanisms of physiologic and aberrant lymphoproliferation in the skin. New York: Plenum Press, 1993:108-11.
35. Scarisbrick JJ, Whittaker S, Evans AV, et al. Prognostic significance of tumor burden in the blood of patients with erythrodermic primary cutaneous T-cell lymphoma. Blood. 2001;97:624-630.